|
by Rao, Ghanta N.
Published 1997
Subjects:
“...Acquired Immunodeficiency Syndrome / drug therapy...”Published 1997
United States Department of Health and Human Services, Public Health Service, National Institutes of Health
|
by Rao, Ghanta N.
Published 1999
Subjects:
“...Acquired Immunodeficiency Syndrome / drug therapy...”Published 1999
United States Department of Health and Human Services, Public Health Service, National Institutes of Health
|
by Rao, Ghanta N.
Published 2000
Subjects:
“...Acquired Immunodeficiency Syndrome / drug therapy...”Published 2000
United States Department of Health and Human Services, Public Health Service, National Institutes of Health
|
by Rao, Ghanta N.
Published 2001
Subjects:
“...Acquired Immunodeficiency Syndrome / drug therapy...”Published 2001
United States Department of Health and Human Services, Public Health Service, National Institutes of Health
|
by Rao, Ghanta N.
Published 2002
Subjects:
“...Acquired Immunodeficiency Syndrome / drug therapy...”Published 2002
United States Department of Health and Human Services, Public Health Service, National Institutes of Health
|
by Rao, Ghanta N.
Published 1999
Subjects:
“...Acquired Immunodeficiency Syndrome / drug therapy...”Published 1999
United States Department of Health and Human Services, Public Health Service, National Institutes of Health
|
by Rao, Ghanta N.
Published 1998
Subjects:
“...Acquired Immunodeficiency Syndrome / drug therapy...”Published 1998
United States Department of Health and Human Services, Public Health Service, National Institutes of Health
|
by Rao, Ghanta N.
Published 2002
Subjects:
“...Drug Therapy, Combination / adverse effects...”Published 2002
U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health
|
by Rao, Ghanta N.
Published 2003
Subjects:
“...Drug Therapy, Combination / adverse effects...”Published 2003
U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health
|
by Rao, Ghanta N.
Published 2002
“...Combination therapy in male mice also resulted in diminished leukocyte, neutrophil, and lymphocyte...”Published 2002
United States Department of Health and Human Services, Public Health Service, National Institutes of Health
|
by Rao, Ghanta N.
Published 1998
“...Female-B mice that received combination therapy had a mild regenerative anemia with reticulocytosis...”Published 1998
United States Department of Health and Human Services, Public Health Service, National Institutes of Health
|
by Rao, Ghanta N.
Published 2000
Published 2000
United States Department of Health and Human Services, Public Health Service, National Institutes of Health
|
by Rao, Ghanta N.
Published 2001
Published 2001
United States Department of Health and Human Services, Public Health Service, National Institutes of Health
|
by Rao, Ghanta N.
Published 2002
“... and isoniazid. Combination therapy also resulted in treatment-related declines in body weight, reticulocytopenia...”Published 2002
U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health
|
by Rao, Ghanta N.
Published 1999
“...The toxicity of AZT and isoniazid combination therapy was assessed in Swiss (CD-1(r)) mice. Gavage...”Published 1999
United States Department of Health and Human Services, Public Health Service, National Institutes of Health
|
by Rao, Ghanta N.
Published 2003
Published 2003
U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health